Bio-Key International is a trusted provider of Identity and Access Management (IAM) and Identity-Bound Biometric solutions. With over 1,000 global customers, including AT&T, the federal government, and 200+ higher education institutions, BIO-key PortalGuard IDaaS is an award-winning IAM platform. It significantly reduces password-related help desk calls, eliminates passwords, secures remote access, prevents phishing attacks, and improves IT team productivity. The platform offers various authentication methods, including the unique Identity-Bound Biometrics (IBB).
Established in 1993 and based in the United States, BIO-key has a proven track record of successful IAM project delivery and strong customer relationships. The company has evolved from providing biometric fingerprint authentication software and scanners to offering a mobile application, BIO-key MobileAuth with PalmPositive, utilizing palm scanning for user authentication.
The latest investment of $3.75M Post-IPO Equity in BIO-key was made on 30 October 2023. Despite no specific investor names provided, this funding could further propel BIO-key’s position as a global leader in biometrics and enhance its IAM solutions, continuing to attract high-profile clients who prioritize robust identity and access management.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity - Bio | $3.75M | - | 30 Oct 2023 | |
Post-IPO Equity - Bio | $3.70M | - | 11 Nov 2013 |
No recent news or press coverage available for BIO-key International, Inc..